Recommendations for folate intake in women: Implications for public health strategies;Recomendações para ingestão de folato por mulheres: Implicações para as estratégias de saúde pública

Cadernos de Saude Publica

Volumn 26, Issue 11, 2010, Pages 2011-2026

  Almeida, Lana Carneiro ^a   Cardoso, Marly Augusto ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Folic Acids; Nutritional Epidemiology; Pteroylpolyglutamic Acids

Indexed keywords

EID: 78650964126     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/S0102-311X2010001100003     Document Type: Review

References (103)

1. World Health Organization. The World Health Report 2002. Reducing risks, promoting healthy life. Geneva: World Health Organization; 2002.
2. World Health Organization. Making a difference in countries: strategic approach to improving maternal and newborn survival and health. Geneva: World Health Organization; 2006.
3. World Health Organization. Women's health. Geneva: World Health Organization; 2001.
4. Subramoney S, Gupta PC. Anaemia in pregnancy. Indian J Med Res 2008; 128:780-1.
5. Jamil KM, Rahman AS, Bardhan PK, Khan AI, Chowdhury F, Sarker SA, et al. Micronutrients and anaemia. J Health Popul Nutr 2008; 26:340-55.
6. Tamura T, Picciano MF. Folate and human reproduction. Am J Clin Nutr 2006; 83:993-1016.
7. Lumley J, Watson L, Watson M, Bower C. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database Syst Rev 2001; (3):CD001056.
8. Sanderson P, McNulty H, Mastroiacovo P, McDowell IF, Melse-Boonstra A, Finglas PM, et al. Folate bioavailability: UK Food Standards Agency Workshop Report. Br J Nutr 2003; 90:473-9.
9. McNulty H, Scott JM. Intake and status of folate and related B-vitamins: considerations and challenges in achieving optimal status. Br J Nutr 2008; 99 Suppl 3:S48-54.
10. Food and Nutrition Board, Institute of Medicine. DRI: dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington DC: National Academy Press; 1998.
11. Smail SA. Dietary supplements in pregnancy. J R Coll Gen Pract 1981; 31:707-11.
12. Ashfield-Watt PA, Pullin CH, Whiting JM, Clark ZE, Moat SJ, Newcombe RG, et al. Methylenetetrahydrofolate reductase 677C-->T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr 2002; 76:180-6.
13. MRC Vitamin Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338:131-7.
14. Selhub J, Rosenberg IH. Public health significance of supplementation or fortification of grain products with folic acid. Food Nutr Bull 2008; 29(2 Suppl):S173-6.
15. World Health Organization. Nutritional anemia. Geneva: World Health Organization; 2007.
16. World Health Organization. Global database on anaemia. Geneva: World Health Organization; 2008.
17. McLean E, de Benoist B, Allen LH. Review of the magnitude of folate and vitamin B12 deficiencies worldwide. Food Nutr Bull 2008; 29(2 Suppl):S38-51.
18. Metz J. A high prevalence of biochemical evidence of vitamin B12 or folate deficiency does not translate into a comparable prevalence of anemia. Food Nutr Bull 2008; 29(2 Suppl):S74-85.
19. Batista Filho M, Souza AI, Miglioli TC, Santos MC. Anemia e obesidade: um paradoxo da transição nutricional brasileira. Cad Saúde Pública 2008; 24 Suppl 2:S247-57.
20. Fabian C, Olinto MTA, Dias-da-Costa JS, Bairros F, Nácul LC. Prevalência de anemia e fatores associados em mulheres adultas residentes em São Leopoldo, Rio Grande do Sul, Brasil. Cad Saúde Pública 2007; 23:1199-205.
21. World Health Organization. Weekly Iron-Folic Acid Supplementation (WIFS) in women of reproductive age: its role in promoting optimal maternal and child health. Geneva: World Health Organization; 2009.
22. Pena-Rosas JP, Viteri FE. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database Syst Rev 2006; (4):CD004736.
23. Coordenação-Geral da Política de Alimentação e Nutrição. Programa Nacional de Suplementação de Ferro: público a ser assistido e conduta de intervenção. http://nutricao.saude.gov.br/nutricao/ferro_info_publico.php?exibe_pagin a=ferro_programa_publico (accessed on 26/Aug/2008).
24. Food and Nutrition Board, Institute of Medicine. DRI: dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington DC: National Academy Press; 1989.
25. Chen CP. Syndromes, disorders and maternal risk factors associated with neural tube defects (II). Taiwan J Obstet Gynecol 2008; 47:10-7.
26. Blom HJ, Shaw GM, den Heijer M, Finnell RH. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 2006; 7:724-31.
27. Thomas P, Fenech M. Methylenetetrahydrofolate reductase, common polymorphisms, and relation to disease. Vitam Horm 2008; 79:375-92.
28. Boyles AL, Billups AV, Deak KL, Siegel DG, Mehltretter L, Slifer SH, et al. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect 2006; 114:1547-52.
29. Boyles AL, Hammock P, Speer MC. Candidate gene analysis in human neural tube defects. Am J Med Genet C Semin Med Genet 2005; 135C:9-23.
30. De Marco P, Merello E, Calevo MG, Mascelli S, Raso A, Cama A, et al. Evaluation of a methylenetetrahydrofolate-dehydrogenase 1958G>A polymorphism for neural tube defect risk. J Hum Genet 2006; 51:98-103.
31. Doudney K, Grinham J, Whittaker J, Lynch SA, Thompson D, Moore GE, et al. Evaluation of folate metabolism gene polymorphisms as risk factors for open and closed neural tube defects. Am J Med Genet A 2009; 149A:1585-9.
32. Beaudin AE, Stover PJ. Insights into metabolic mechanisms underlying folate-responsive neural tube defects: a minireview. Birth Defects Res A Clin Mol Teratol 2009; 85:274-84.
33. Welch AD. Folic acid: discovery and the exciting first decade. Perspect Biol Med 1983; 27:64-75
34. Zeisel SH. Importance of methyl donors during reproduction. Am J Clin Nutr 2009; 89:673S-677S.
35. Yang QH, Botto LD, Gallagher M, Friedman JM, Sanders CL, Koontz D, et al. Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am J Clin Nutr 2008; 88:232-46.
36. Patterson D. Folate metabolism and the risk of Down syndrome. Downs Syndr Res Pract 2008; 12:93-7.
37. Weingärtner J, Lotz K, Fanghänel J, Gedrange T, Bienengräber V, Proff P. Induction and prevention of cleft lip, alveolus and palate and neural tube defects with special consideration of B vitamins and the methylation cycle. J Orofac Orthop 2007; 68:266-77.
38. Grewal J, Carmichael SL, Song J, Shaw GM. Neural tube defects: an analysis of neighbourhood- and individual-level socio-economic characteristics. Paediatr Perinat Epidemiol 2009; 23:116-24.
39. Wynn A, Wynn M. The effects of food shortage on human reproduction. Nutr Health 1993; 9:43-52.
40. Chen CP. Syndromes, disorders and maternal risk factors associated with neural tube defects (IV).Taiwan J Obstet Gynecol 2008; 47:141-50.
41. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287:356-9.
42. Ray JG, Thompson MD, Vermeulen MJ, Meier C, Wyatt PR, Wong PY, et al. Metabolic syndrome features and risk of neural tube defects. BMC Pregnancy Childbirth 2007; 7:21.
43. Oakley Jr. GP, Johnston Jr. RB. Balancing benefits and harms in public health prevention programmes mandated by governments. BMJ 2004; 329:41-3.
44. Czeizel AE, Dudás I. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327:1832-5.
45. Department of Health. Folic acid and the prevention of neural tube defects. Report from an Expert Advisory Committee. London: Department of Health; 1992.
46. Kramer MS. The Epidemiology of adverse pregnancy outcomes: an overview. J Nutr 2003; 133(5Suppl 2):1592S-1596S.
47. van der Pal-de Bruin KM, de Walle HE, Jeeninga W, de Rover C, Cornel MC, de Jong-van den Berg LT, et al. The Dutch 'Folic Acid Campaign': have the goals been achieved? Paediatr Perinat Epidemiol 2000; 14:111-7.
48. Centers for Disease Control and Prevention. Trends in wheat-flour fortification with folic acid and iron: worldwide, 2004 and 2007. MMWR Morb Mortal Wkly Rep 2008; 57:8-10.
49. Horovitz DDG, Llerena Jr. JC, Mattos RA. Atenção aos defeitos congênitos no Brasil: panorama atual. Cad Saúde Pública 2005; 21:1055-64.
50. Ray JG, Singh G, Burrows RF. Evidence for suboptimal use of periconceptional folic acid supplements globally. BJOG 2004; 111:399-408.
51. Stockley L, Lund V. Use of folic acid supplements, particularly by low-income and young women: a series of systematic reviews to inform public health policy in the UK. Public Health Nutr 2008; 11:807-21.
52. Kim MH, Han JY, Cho YJ, Ahn HK, Kim JO, Ryu HM, et al. Factors associated with a positive intake of folic acid in the periconceptional period among Korean women. Public Health Nutr 2009; 12:468-71.
53. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary supplement use by US adults: data from the National Health and Nutrition Examination Survey, 1999-2000. Am J Epidemiol 2004; 160:339-49.
54. Mezzomo CL, Garcias GL, Sclowitz ML, Sclowitz IT, Brum CB, Fontana T, et al. Prevenção de defeitos do tubo neural: prevalência do uso da suplementação de ácido fólico e fatores associados em gestantes na cidade de Pelotas, Rio Grande do Sul, Brasil. Cad Saúde Pública 2007; 23:2716-26.
55. Botto LD, Moore CA, Khoury MJ, Erickson JD. Neural-tube defects. N Engl J Med 1999; 341:1509-19.
56. Nguyen P, Tam C, O'Connor DL, Kapur B, Koren G. Steady state folate concentrations achieved with 5 compared with 1.1mg folic acid supplementation among women of childbearing age. Am J Clin Nutr 2009; 89:844-52.
57. Carmo TA, Nitrini SM. Prescrições de medicamentospara gestantes: um estudo farmacoepidemiológico. Cad Saúde Pública 2004; 20:1004-13.
58. Bell KN, Oakley Jr. GP. Update on prevention of folic acid-preventable spina bifida and anencephaly. Birth Defects Res A Clin Mol Teratol 2009; 85:102-7.
59. Boulet SL, Yang Q, Mai C, Kirby RS, Collins JS, Robbins JM, et al. Trends in the postfortification prevalence of spina bifida and anencephaly in the United States. Birth Defects Res A Clin Mol Teratol 2008; 82:527-32.
60. Godwin KA, Sibbald B, Bedard T, Kuzeljevic B, Lowry RB, Arbour L. Changes in frequencies of select congenital anomalies since the onset of folic acid fortification in a Canadian birth defect registry. Can J Public Health 2008; 99:271-5.
61. Nazer J, Cifuentes L, Aguila A, Juárez ME, Cid MP, Godoy ML, et al. Efecto de la fortificación de la harina con ácido fólico sobre la evolución de las tasas de prevalencia al nacimiento de malformaciones congénitas en los hospitales chilenos del ECLAMC. Rev Méd Chile 2007; 135:198-204.
62. Hoey L, McNulty H, Askin N, Dunne A, Ward M, Pentieva K, et al. Effect of a voluntary food fortification policy on folate, related B vitamin status, and homocysteine in healthy adults. Am J Clin Nutr 2007; 86:1405-13.
63. Kim YI. Folate and colorectal cancer: an evidencebased critical review. Mol Nutr Food Res 2007; 51:267-92.
64. Nelen WL, Blom HJ, Steegers EA, den Heijer M, Thomas CM, Eskes TK. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss. Obstet Gynecol 2000; 95:519-24.
65. Hirsch S, de la Maza P, Barrera G, Gattás V, Petermann M, Bunout D. The Chilean flour folic acid fortification program reduces serum homocysteine levels and masks vitamin B-12 deficiency in elderly people. J Nutr 2002;132:289-91.
66. Nazer J, Aguila A, Cifuentes L. La frecuencia de nacimientos de gemelos aumentó en un hospital chileno coincidiendo con el consumo periconcepcional de harina fortificada con ácido fólico. Rev Méd Chile 2006; 134:48-52.
67. Wald NJ, Law MR, Morris JK, Wald DS. Quantifying the effect of folic acid. Lancet 2001; 358:2069-73.
68. Choumenkovitch SF, Selhub J, Wilson PW, Rader JI, Rosenberg IH, Jacques PF. Folic acid intake from fortification in United States exceeds predictions. J Nutr 2002; 132:2792-8.
69. Jacques PF, Selhub J, Bostom AG, Wilson PW, Rosenberg IH. The effect of folic acid fortification on plasma folate and total homocysteine concentrations. N Engl J Med 1999; 340:1449-54.
70. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, et al. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr 2007; 86:718-27.
71. Quinlivan EP, Gregory 3rd JF. Reassessing folic acid consumption patterns in the United States (1999 2004): potential effect on neural tube defects and overexposure to folate. Am J Clin Nutr 2007; 86:1773-9.
72. Hickling S, Hung J, Knuiman M, Jamrozik K, Mc-Quillan B, Beilby J, et al. Impact of voluntary folate fortification on plasma homocysteine and serum folate in Australia from 1995 to 2001: a population based cohort study. J Epidemiol Community Health 2005; 59:371-6.
73. Persad VL, Van den Hof MC, Dubé JM, Zimmer P. Incidence of open neural tube defects in Nova Scotia after folic acid fortification. CMAJ 2002; 167:241-5.
74. Liu S, West R, Randell E, Longerich L, O'Connor KS, Scott H, et al. A comprehensive evaluation of food fortification with folic acid for the primary prevention of neural tube defects. BMC Pregnancy Childbirth 2004; 4:20.
75. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC, et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic acid fortification. Pediatrics 2009; 123:917-23.
76. o. 344, de 13 de dezembro de 2002. Aprova o regulamento técnico para a fortificação das farinhas de trigo e milho com ferro e ácido fólico. http://e-le gis.anvisa.gov.br/legis/resol/2002/344_02rdc.htm (accessed on 30/Jun/2008).
77. Instituto Nacional de Metrologia, Normalização e Qualidade Industrial. Produtos de festa junina-amendoim, fubá de milho e leite de coco. http://www.inmetro.gov.br/consumidor/produtos/festa Junina.asp (accessed on 26/Jun/2005).
78. Soeiro BT, Boen TR, Wagner R, Lima-Pallone JA. Physico-chemical quality and homogeneity of folic acid and iron in enriched flour using principal component analysis. Int J Food Sci Nutr 2009; 27:1-13.
79. Pacheco SS, Braga C, Souza AI, Figueiroa JN. Efeito da fortificação alimentar com ácido fólico na prevalência de defeitos do tubo neural. Rev Saúde Pública 2009; 43:565-71.
80. Castilla EE, Orioli IM, Lopez-Camelo JS, Dutra MG, Nazer-Herrera J; Latin American Collaborative Study of Congenital Malformations. Preliminary data on changes in neural tube defect prevalence rates after folic acid fortification in South America. Am J Med Genet A 2003; 123A:123-8.
81. Flynn MA, Anderson WA, Burke SJ, Reilly A. Session 1: public health nutrition. Folic acid food fortification: the Irish experience. Proc Nutr Soc 2008; 67:381-9.
82. World Health Organization. Guidelines on food fortification with micronutrients. Geneva: World Health Organization; 2006.
83. Instituto Brasileiro de Geografia e Estatística. Pesquisa de Orçamentos Familiares (POF) 2002-2003: aquisição alimentar domiciliar per capita. Rio de Janeiro: Institu to Brasileiro de Geografia e Estatística; 2004.
84. Fletcher RJ, Bell IP, Lambert JP. Public health aspects of food fortification: a question of balance. Proc Nutr Soc 2004; 63:605-14.
85. Sudha ML, Leelavathi K. Influence of micronutrients on rheological characteristics and breadmaking quality of flour. Int J Food Sci Nutr 2008; 59:105-15.
86. Rosado JL, Camacho Solís R, Bourges H. Adición de vitaminas y minerales a harinas de maíz y de trigo en México. Salud Pública Méx 1999; 41:130-7.
87. Wright AJ, Dainty JR, Finglas PM. Folic acid metabolism in human subjects revisited: potential implications for proposed mandatory folic acid fortification in the UK. Br J Nutr 2007; 98:667-75.
88. Powers HJ. Folic acid under scrutiny. Br J Nutr 2007; 98:665-6.
89. Troen AM, Mitchell B, Sorensen B, Wener MH, Johnston A, Wood B, et al. Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 2006; 136:189-94.
90. Kelly P, McPartlin J, Goggins M, Weir DG, Scott JM. Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr 1997; 65:1790-5.
91. Bailey SW, Ayling JE. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Proc Natl Acad Sci U S A 2009; 106:15424-9.
92. Ashokkumar B, Mohammed ZM, Vaziri ND. Effect of folate oversupplementation on folate uptake by human intestinal and renal epithelial cells. Am J Clin Nutr 2007; 86:159-66.
93. Markle HV. Unmetabolized folic acid and masking of cobalamin deficiency. Am J Clin utr 1997; 66:1480-1.
94. Ericson U, Sonestedt E, Gullberg B, Olsson H, Wirfält E. High folate intake is associated with lower breast cancer incidence in postmenopausal women in the Malmö Diet and Cancer cohort. Am J Clin Nutr 2007; 86:434-43.
95. Stolzenberg-Solomon RZ, Chang SC, Leitzmann MF, Johnson KA, Johnson C, Buys SS, et al. Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Clin Nutr 2006; 83:895-904.
96. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007; 297:2351-9.
97. Lladó V, Terés S, Higuera M, Alvarez R, Noguera-Salva MA, Halver JE, et al. Pivotal role of dihydrofolate reductase knockdown in the anticancer activity of 2-hydroxyoleic acid. Proc Natl Acad Sci U S A 2009; 106:13754-8.
98. Basten GP, Duthie SJ, Pirie L, Vaughan N, Hill MH, Powers HJ. Sensitivity of markers of DNA stability and DNA repair activity to folate supplementation in healthy volunteers. Br J Cancer 2006; 94:1942-7.
99. Mills JL. Fortification of foods with folic acid: how much is enough? N Engl J Med 2000; 342:1442-5.
100. Morris MS, Jacques PF, Rosenberg IH, Selhub J. Folate and vitamin B-12 status in relation to anemia, macrocytosis, and cognitive impairment in older Americans in the age of folic acid fortification. Am J Clin Nutr 2007; 85:193-200.
101. Kondo A, Kamihira O, Shimosuka Y, Okai I, Gotoh M, Ozawa H. Awareness of the role of folic acid, dietary folate intake and plasma folate concentration in Japan. J Obstet Gynaecol Res 2005; 31:172-7.
102. Wharton B, Booth I. Fortification of flour with folic acid. BMJ 2001; 323:1198-9.
103. Eichholzer M, Tönz O, Zimmermann R. Folic acid: a public-health challenge. Lancet 2006; 367: 1352-61.